Maximus (NYSE:MMS) Director Sells $53,609.50 in Stock

Maximus, Inc. (NYSE:MMS) Director Jan Madsen sold 742 shares of Maximus stock in a transaction that occurred on Tuesday, March 17th. The shares were sold at an average price of $72.25, for a total transaction of $53,609.50. Following the transaction, the director directly owned 20,795 shares in the company, valued at approximately $1,502,438.75. This trade represents a 3.45% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.

Maximus Price Performance

Maximus stock opened at $68.74 on Friday. The firm has a fifty day moving average of $82.82 and a 200-day moving average of $85.22. Maximus, Inc. has a 52-week low of $64.68 and a 52-week high of $100.00. The company has a quick ratio of 2.34, a current ratio of 2.34 and a debt-to-equity ratio of 0.88. The firm has a market capitalization of $3.75 billion, a P/E ratio of 10.46 and a beta of 0.59.

Maximus (NYSE:MMS) last posted its earnings results on Thursday, February 5th. The health services provider reported $1.85 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.01. Maximus had a net margin of 6.92% and a return on equity of 25.30%. The business had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.37 billion. During the same quarter in the previous year, the business posted $1.61 EPS. The business’s quarterly revenue was down 4.1% on a year-over-year basis. Maximus has set its FY 2026 guidance at 8.050-8.350 EPS. As a group, analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, March 2nd. Investors of record on Friday, February 13th were given a dividend of $0.33 per share. This is a boost from Maximus’s previous quarterly dividend of $0.30. The ex-dividend date of this dividend was Friday, February 13th. This represents a $1.32 annualized dividend and a yield of 1.9%. Maximus’s dividend payout ratio is presently 20.09%.

Institutional Trading of Maximus

Several institutional investors have recently added to or reduced their stakes in the stock. Rockefeller Capital Management L.P. grew its holdings in Maximus by 59.7% during the 4th quarter. Rockefeller Capital Management L.P. now owns 1,659 shares of the health services provider’s stock worth $143,000 after acquiring an additional 620 shares in the last quarter. Hsbc Holdings PLC grew its stake in Maximus by 497.8% in the fourth quarter. Hsbc Holdings PLC now owns 13,886 shares of the health services provider’s stock worth $1,205,000 after purchasing an additional 11,563 shares in the last quarter. River Road Asset Management LLC increased its holdings in Maximus by 236.1% in the fourth quarter. River Road Asset Management LLC now owns 823,262 shares of the health services provider’s stock valued at $71,064,000 after buying an additional 578,326 shares during the last quarter. EP Wealth Advisors LLC bought a new stake in Maximus in the fourth quarter valued at about $329,000. Finally, Empowered Funds LLC lifted its holdings in Maximus by 266.4% during the 4th quarter. Empowered Funds LLC now owns 9,544 shares of the health services provider’s stock worth $824,000 after buying an additional 6,939 shares during the last quarter. 97.21% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of research firms have recently commented on MMS. Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Monday, February 23rd. Zacks Research upgraded shares of Maximus from a “hold” rating to a “strong-buy” rating in a report on Tuesday, December 30th. Finally, Weiss Ratings cut shares of Maximus from a “buy (b)” rating to a “hold (c+)” rating in a research report on Tuesday, February 24th. One research analyst has rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of “Buy”.

About Maximus

Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.